Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.
about
Early versus late chest radiotherapy in patients with limited-stage small cell lung cancerTreatment for small cell lung cancer, where are we now?-a reviewHighlights for ESMO 40: celebration review for lifetime achievement awardsImmune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis.Phase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer.[A prospective randomized study of the radiotherapy volume for limited-stage small cell lung cancer: a preliminary report].[A meta-analysis of the timing of chest radiotherapy in patients with limited-stage small cell lung cancer].Effect of early chemoradiotherapy in patients with limited stage small cell lung cancer.A meta-analysis of randomized controlled trials comparing early and late concurrent thoracic radiotherapy with etoposide and cisplatin/carboplatin chemotherapy for limited-disease small-cell lung cancer.Feasibility study of chemoradiotherapy followed by amrubicin and cisplatin for limited-disease small cell lung cancerNovel systemic therapies for small cell lung cancerManagement of small-cell lung cancer: incremental changes but hope for the futureProspective study on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients (pts) with stage IIIB and IV lung cancer-CSP-HOR 13.Small cell lung cancer: therapies and targetsClinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancerFeasibility and efficacy of simultaneous integrated boost intensity-modulated radiation therapy in patients with limited-disease small cell lung cancerNew approaches for small-cell lung cancer: local treatments.Chemotherapy for small cell lung cancer: a comprehensive reviewLimited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms.Progress in treatment of small-cell lung cancer: role of CPT-11.Small cell lung cancer: from molecular biology to novel therapeutics.Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer: analysis of CALGB phase III trial 9235Efficacy of 3D conformal thoracic radiotherapy for extensive-stage small-cell lung cancer: A retrospective study.Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.Evaluation of the role of remission status in a heterogeneous limited disease small-cell lung cancer patient cohort treated with definitive chemoradiotherapyIncreased Biological Effective Dose of Radiation Correlates with Prolonged Survival of Patients with Limited-Stage Small Cell Lung Cancer: A Systematic Review.Does the response to induction chemotherapy impact the timing of thoracic radiotherapy for limited-stage small-cell lung cancer?Surgical intervention for small-cell lung cancer: what is the surgical role?Definitive chemoradiotherapy of limited-disease small cell lung cancer: Retrospective analysis of new predictive factors affecting treatment resultsVorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells.Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studiesChemoradiotherapy for lung cancer.Lung cancer: Biology and treatment options.Simultaneous integrated dose reduction intensity-modulated radiotherapy applied to an elective nodal area of limited-stage small-cell lung cancer.Small cell lung cancer: treatment review.Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study.c-Met Mutational Analysis in the Sema and Juxtamembrane Domains in Small-Cell-Lung-Cancer.Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO)Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival.
P2860
Q24245945-E0861ED8-31A9-40BD-BEDD-8E925A90ECE2Q26767023-4E8D25FF-B1FF-46F7-A407-F4CBC0D5EEBCQ28075787-B6F4DB76-12E9-4BAE-AABE-0F9E520AE8E6Q28079771-5902DBB0-D14D-4492-981B-C91A050378C4Q30248898-A9B4152A-B0DB-4BE7-8924-4D1540299E45Q33370887-77187F4A-B5E1-40D9-B80D-7BCE091B25F7Q33391093-28323B11-D4F3-468F-8063-A88F4404D0C7Q33391864-00ADD938-509A-4EB1-9199-5E6E132E009FQ33413185-4BF53D04-82AB-4ADF-904E-D97AE5584276Q33416668-20DAFB2B-5852-4413-8B55-B0D0E29ED6DEQ33429048-BAF664C5-EAAB-44B8-A551-832EAD16E939Q33862245-6042F72F-9443-4091-917E-B7C13E36FFD5Q34013813-518B7F99-B832-4E7A-8F44-3E5A1DAEC66EQ34041808-FC2D1848-C079-4D3E-8DF4-EDCCB0D5CFDFQ34250859-E2FA7750-5722-443B-9482-422BA1A7232EQ34502009-ECB4FB03-C6ED-4176-B70A-7DAE5917E011Q34727914-29A3442E-F065-420A-8F51-12941A435F03Q35198443-0234912A-3FE2-4FE3-B0E0-FC23AE993797Q35569379-17683384-B2A2-4AC9-996F-DBCF8FA162DCQ35583915-C3E36020-84C1-495A-B494-4C4602DAF030Q35608220-12771EBE-E909-469C-97C9-FD42BB6D6095Q35608984-47813DC0-C873-4C05-98BA-AEBD876F7B01Q35736470-C4BF9A03-4B1C-4A98-A3BD-85613744AEE3Q35870332-635C8AA5-3C38-4563-A343-FF6658DFA48FQ35949757-B2D7A51B-447C-487C-B872-12211EF31F66Q35956628-1E393338-056B-4029-B531-04F2C1DFA0D5Q36030323-27A26FDF-D261-4AB6-AA8A-DF45B57494E6Q36051709-5134ACF6-A54C-4A25-9343-2E60C2E92C85Q36072024-BBE8E28B-BE74-4CE3-A9BB-75963E7EE090Q36126531-8871E9C1-060A-41DB-8862-858E94404492Q36184617-D414A8B8-D633-4495-93B0-60C38BB8235DQ36200218-3E3F343C-F392-45B8-931A-A24447A8A746Q36327084-CEBD5ACE-3774-4E70-881B-12CA70C4B477Q36328370-225D0294-3111-4A03-A6EB-E67685E20E96Q36334696-9F717178-94EC-4DD6-99B6-296B11CF7719Q36458604-F5E7181C-CA35-42F7-B80E-75B9D69B3B92Q36613973-7407AB3C-1043-43D9-92D8-8B15E18089F9Q36812161-94B23A1C-A41B-4B97-B594-56BDA1353D83Q36833865-4723B50D-6F62-42BA-BA7A-68F5B22EBA8EQ36848102-20816FFE-2BE2-48E6-9E16-B00F9E9E76C7
P2860
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Phase III study of concurrent ...... cal Oncology Group Study 9104.
@en
Phase III study of concurrent ...... cal Oncology Group Study 9104.
@nl
type
label
Phase III study of concurrent ...... cal Oncology Group Study 9104.
@en
Phase III study of concurrent ...... cal Oncology Group Study 9104.
@nl
prefLabel
Phase III study of concurrent ...... cal Oncology Group Study 9104.
@en
Phase III study of concurrent ...... cal Oncology Group Study 9104.
@nl
P2093
P356
P1476
Phase III study of concurrent ...... cal Oncology Group Study 9104.
@en
P2093
Akira Yokoyama
Haruhiko Fukuda
Kazumasa Noda
Koshiro Watanabe
Masaaki Kawahara
Masahiro Fukuoka
Minoru Takada
Nagahiro Saijo
Soichiro Yokota
Takahiko Sugiura
P304
P356
10.1200/JCO.2002.12.071
P407
P577
2002-07-01T00:00:00Z